ArticleBreast cancer (Tokyo, Japan)2024

Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy.

Mellissa Williamson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.